Tag Archive for: Secarna Pharmaceuticals

Konstantin Petropoulos, Ph.D., MBA, CEO & Managing ­Director, Secarna PharmaceuticalsSecarna
RNA Technologies

Next-gen oligonucleotides to transform patient care

Secarna Pharmaceuticals is redefining the discovery and development of ­oligonucleotide therapeutics to address hard-to-treat disorders. The Company is planning to raise a Series A to advance its lead oncology asset, SECN-15, into Phase 1/2. Secarna is supported by global partnerships that validate their expertise and accelerate development.

Read more
© NIH
partnership

Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals

Antisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
 

Read more